Mutations in the gene encoding immunoglobulin μ-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1
Nature Genetics2001Vol. 29(1), pp. 75–77
Citations Over TimeTop 10% of 2001 papers
Katja Grohmann, Markus Schuelke, Alexander Diers, Katrin Hoffmann, Barbara Lucke, Coleen Adams, Enrico Bertini, Hajnalka Leonhardt-Horti, Francesco Muntoni, Robert Ouvrier, Arne Pfeufer, Rainer Rossi, Lionel Van Maldergem, Jo M. Wilmshurst, Thomas F. Wienker, Michael Sendtner, Sabine Rudnik‐Schöneborn, Klaus Zerres, Christoph Hübner
Related Papers
- → Valproic acid increases SMN levels in spinal muscular atrophy patient cells(2003)288 cited
- → The First Orally Deliverable Small Molecule for the Treatment of Spinal Muscular Atrophy(2020)88 cited
- → SMN-Inducing Compounds For The Treatment Of Spinal Muscular Atrophy(2012)34 cited
- → Deletion Analysis of SMN1 Exon 7 Alone May Be Necessary and Sufficient for the Diagnosis of Spinal Muscular Atrophy(2011)3 cited
- → AB140. Ten years experiences of diagnosis spinal muscular atrophy using molecular techniques(2015)